Ptc Therapeutics (PTCT) EBIT (QoQ) (2012 - 2026)
Powered by 
Analysis
Ptc Therapeutics (PTCT) EBIT (QoQ) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Ptc Therapeutics | 5.81 Bn | 3.58 Bn | 340.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 231.36% |
| Mar 31, 2026 | 163.01% |
| Dec 31, 2025 | -2,465.68% |
| Sep 30, 2025 | 108.63% |
| Jun 30, 2025 | -103.60% |
| Mar 31, 2025 | 697.47% |
| Dec 31, 2024 | -197.91% |
| Sep 30, 2024 | -35.54% |
| Jun 30, 2024 | 11.52% |
| Mar 31, 2024 | -880.98% |
| Dec 31, 2023 | 104.93% |
| Sep 30, 2023 | 43.61% |
| Jun 30, 2023 | -78.16% |
| Mar 31, 2023 | 41.29% |
| Dec 31, 2022 | -193.81% |
| Sep 30, 2022 | 26.17% |
| Jun 30, 2022 | -6.75% |
| Mar 31, 2022 | -2.11% |
| Dec 31, 2021 | 8.97% |
| Sep 30, 2021 | 5.50% |